<i>HER2</i> somatic mutations are associated with poor survival in HER2‐negative breast cancers
Tonghui Wang(China University of Mining and Technology), Yuntao Xie(Peking University), Ye Xu(Fudan University Shanghai Cancer Center), Jinfeng Li(Hebei Medical University), Zhaoqing Fan(Daqing Oilfield General Hospital), Tianfeng Wang(Peking University), Tie Fan(Ministry of Education), Hua Yuan(Peking University), Shuyan Sheng(Anhui Medical University), Benyao Lin(Ministry of Education), Tao Ouyang(Peking University)
Cited by 67
Related Papers
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
|Journal of Medicinal Chemistry|2013|221
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
|Journal of Clinical Oncology|2009|218
A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors
|Medicinal Research Reviews|2015|181